Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
United States: Food and Drug Administration
TLK286.2003
NCT00038428
June 2001
July 2005
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
USC/Norris Comprehensive Cancer Center | Los Angeles, California 90033-0800 |
M.D. Anderson Cancer Center | Houston, Texas 77030 |